The Effectiveness and Efficacy of the Combination of Pharmacotherapy With the Two New Recovery-oriented Programs, RECOVERYTRSGR (Treatment Resistant Schizophrenia) and RECOVERYTRSBDGR (Treatment Resistant Bipolar Disorder)
Status: Active_not_recruiting
Location: See location...
Intervention Type: Combination product
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
The effectiveness and efficacy of the combination of pharmacotherapy with the two new recovery-oriented programs, RECOVERYTRSGR for patients with treatment- resistant schizophrenia and RECOVERYTRSBDGR for patients with treatment- resistant bipolar disorder.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:
• age 18-65
• IQ ≥ 80
• Diagnosis TRS.
• age 18-65
• IQ ≥ 80
• Diagnosis TRSBD.
Locations
Other Locations
Greece
Private practice of Dr. S. Rakitzi and Dr. P. Georgila ILISION 34 15771 ATHENS GREECE
Athens
Time Frame
Start Date: 2025-06-04
Completion Date: 2027-12-20
Participants
Target number of participants: 84
Treatments
Experimental: Group A
Pharmacotherapy and RECOVERYTRSGR 22 participants
Active_comparator: Group B
Pharmacotherapy and TAU. 20 participants
Experimental: Group C
Pharmacotherapy and RECOVERYTRSBDGR. 22 participants
Active_comparator: Group D
Pharmacotherapy and TAU. 20 participants
Related Therapeutic Areas
Sponsors
Leads: Dr. Stavroula Rakitzi